MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The Role of Cortisol a Mediator in Influencing Cognitive Function

    DT. Akramova (Tashkent, Uzbekistan)

    Objective: To explore cortisol's impact on cognitive decline and life quality in Parkinson's disease (PD) Background: PD patients exhibit varied symptoms, including cognitive deficits and…
  • 2024 International Congress

    Diagnostic Challenges in Functional Neurological Disorder: Convergent Psychogenic Non-Epileptic Seizures and Psychosis

    D. Nolasco, R. Holbert, B. Carr (Gainesville, USA)

    Objective: To dissect the diagnostic challenges in distinguishing Functional Neurological Disorder (FND) coexisting with psychosis, highlighting the imperative for comprehensive and nuanced neuro-psychiatric assessment. Background:…
  • 2024 International Congress

    The relationship between dimensions of mental health and markers of Parkinson’s disease risk in the UK Biobank

    B. Attaallah, S. Waters, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the relationship between indicators of mental health, and neuroimaging and genetic markers of Parkinson’s disease (PD). Background: PD is associated with a…
  • 2024 International Congress

    Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy

    S. Bhushan, Mph, S. Brillman, Md (Palo Alto, USA)

    Objective: We describe a patient who developed amantadine-induced craniofacial myoclonus with speech impairment. Few cases have been reported [1], thus we offer an additional case…
  • 2024 International Congress

    Malignant Functional Movement Disorders in Children, Experience from a Tertiary Care Center

    M. Hull, A. Boehnke, S. Rahman, M. Salazar, M. Maldonado-Duran, M. Parnes, J. Jankovic (Houston, USA)

    Objective: We evaluated patients with FMD and identified those with troublesome or even disabling symptoms or complications due to the treatment of the condition. Background:…
  • 2024 International Congress

    Drug-induced tremors: A scoping review to assess knowledge gaps, controversies, and future directions

    S. Desai, D. Desai (Anand, India)

    Objective: This scoping review aims to assess the current state of knowledge regarding drug-induced tremors, identify critical knowledge gaps, and controversies, and outline a future…
  • 2024 International Congress

    Neuroprotective Efficacy of Ethanolic Extract from Amorphophallus Paeoniifolius Tuber Against Haloperidol-Induced Parkinson’s Disease Model

    R. Kumar, S. Choudhary (Handia,, India)

    Objective: This study aimed to evaluate the neuroprotective and antiparkinsonian effects of the ethanolic extract of Amorphophallus paeoniifolius tuber (APT) against haloperidol-induced Parkinson’s Disease (PD)…
  • 2024 International Congress

    Functional Motor Disorders in pediatrics: motor patterns and clinical correlates.

    V. Baglioni, C. Geroin, D. Esposito, F. Teatini, A. Tessitore, G. Calandra-Buonaura, M. Zibetti, R. Erro, F. Morgante, A. Albanese, F. Bono, M. Zappia, G. Defazio, E. Marcuzzo, A. Sandri, M. Tinazzi (Rome, Italy)

    Objective: The aim of this study was to describe FMDs clinical manifestations in pediatrics, including non-motor symptoms and other functional neurological disorders (FNDs) and to…
  • 2024 International Congress

    Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model

    S. -, V. Parcha (Dehardun, India)

    Objective: This research aims to assess whether Ibudilast (IBD), a phosphodiesterase IV (PDE IV) inhibitor, can mitigate the damage induced by 3-nitropropionic acid (3-NP) in…
  • 2024 International Congress

    Association Between Hypertension Timing and Clinical Variables in Parkinson’s Disease: A Retrospective Analysis

    WF. Moguel Cardín, AL. Guerra Anzaldo, GA. Espinosa Cruz, A. Adam Castro, A. Dominguez García, A. Cervantes Arriaga, M. Rodríguez Violante, AJ. Hernández Medrano, G. Rivera Monroy, K. Velázquez Román, RJ. Baños Betancourt, CF. álvarez Hernández, DP. Romero Terán, JC. Delgado Uriarte, NP. Moreno Aldama, MC. Unda Mcfarlane, A. Uribe León (Ciudad de Mexico, Mexico)

    Objective: To investigate the correlation between hypertension and Parkinson's disease (PD) diagnoses' timing and clinical variables. Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder…
  • « Previous Page
  • 1
  • …
  • 304
  • 305
  • 306
  • 307
  • 308
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley